Examining the True Prevalence of Hypercortisolism and Its Impact on Managing Resistant Diabetes - Episode 3
CATALYST Trial Study Design
Published on:
Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE, Ralph DeFronzo, MD , Athena Philis-Tsimikas, MD, John Anderson, MD The expert panel analyze data from the CATALYST trial.
Video content above is prompted by the following:
- Could you review the study design of the CATALYST trial?
- Prevalence phase vs treatment phase
- Patient population
- Screening test for hypercortisolism